Fine-tuning the dose of recombinant human follicle-stimulating hormone alfa to individualize treatment in ovulation induction and ovarian stimulation cycles: a real-world database analysis
We examined the incidence and magnitude of individualized gonadotropin dose adjustments made during cycles of OI or OS, followed by either timed intercourse or intrauterine insemination, with or without oral medications, and assessed the relationship between patient characteristics and dosing changes using real-world evidence.MethodsThis was an observational, retrospective cohort study using electronic medical records from a large US database of fertility centers. Data from patients who had undergone a first recombinant human follicle stimulating hormone alfa (r-hFSH-alfa/follitropin alfa) treated OI/OS cycle followed by t...
Source: Frontiers in Endocrinology - September 1, 2023 Category: Endocrinology Source Type: research
Acupuncture improves the emotion domain and lipid profiles in women with polycystic ovarian syndrome: a secondary analysis of a randomized clinical trial
ConclusionAcupuncture can improve not only the emotional changes in SF-36 scores and ChiQOL scores, but also lipid metabolism, implying that it may have a correlation between emotional change and lipid metabolism. Furthermore, acupuncture can also regulate the changes of serum Ca, K, and Cl.Clinical trial registrationClinicalTrials.gov, identifier NCT01573858. (Source: Frontiers in Endocrinology)
Source: Frontiers in Endocrinology - August 29, 2023 Category: Endocrinology Source Type: research
The clinical value of progestin-primed ovarian stimulation protocol for women with diminished ovarian reserve undergoing IVF/ICSI: a systematic review and meta-analysis
ConclusionsBased on evidence-based results, PPOS protocol seems to improve IVF/ICSI outcomes for women with DOR. More research with larger sample sizes and rigorous designs are required to further explore the value of PPOS among women diagnosed with DOR.Systematic review registrationwww.crd.york.ac.uk, identifier CRD42023430202. (Source: Frontiers in Endocrinology)
Source: Frontiers in Endocrinology - August 21, 2023 Category: Endocrinology Source Type: research
Letrozole More Effective Than Clomiphene for Infertility Treatment Among Individuals With Polycystic Ovary Syndrome
Am Fam Physician. 2023 Aug;108(2):203-204.NO ABSTRACTPMID:37590869 (Source: American Family Physician)
Source: American Family Physician - August 17, 2023 Category: Primary Care Authors: Linda Speer Source Type: research
Letrozole More Effective Than Clomiphene for Infertility Treatment Among Individuals With Polycystic Ovary Syndrome
Am Fam Physician. 2023 Aug;108(2):203-204.NO ABSTRACTPMID:37590869 (Source: American Family Physician)
Source: American Family Physician - August 17, 2023 Category: Primary Care Authors: Linda Speer Source Type: research
Letrozole More Effective Than Clomiphene for Infertility Treatment Among Individuals With Polycystic Ovary Syndrome
Am Fam Physician. 2023 Aug;108(2):203-204.NO ABSTRACTPMID:37590869 (Source: American Family Physician)
Source: American Family Physician - August 17, 2023 Category: Primary Care Authors: Linda Speer Source Type: research
Letrozole More Effective Than Clomiphene for Infertility Treatment Among Individuals With Polycystic Ovary Syndrome
Am Fam Physician. 2023 Aug;108(2):203-204.NO ABSTRACTPMID:37590869 (Source: American Family Physician)
Source: American Family Physician - August 17, 2023 Category: Primary Care Authors: Linda Speer Source Type: research
Letrozole More Effective Than Clomiphene for Infertility Treatment Among Individuals With Polycystic Ovary Syndrome
Am Fam Physician. 2023 Aug;108(2):203-204.NO ABSTRACTPMID:37590869 (Source: American Family Physician)
Source: American Family Physician - August 17, 2023 Category: Primary Care Authors: Linda Speer Source Type: research
Letrozole More Effective Than Clomiphene for Infertility Treatment Among Individuals With Polycystic Ovary Syndrome
Am Fam Physician. 2023 Aug;108(2):203-204.NO ABSTRACTPMID:37590869 (Source: American Family Physician)
Source: American Family Physician - August 17, 2023 Category: Primary Care Authors: Linda Speer Source Type: research
Letrozole More Effective Than Clomiphene for Infertility Treatment Among Individuals With Polycystic Ovary Syndrome
Am Fam Physician. 2023 Aug;108(2):203-204.NO ABSTRACTPMID:37590869 (Source: American Family Physician)
Source: American Family Physician - August 17, 2023 Category: Primary Care Authors: Linda Speer Source Type: research
Letrozole More Effective Than Clomiphene for Infertility Treatment Among Individuals With Polycystic Ovary Syndrome
Am Fam Physician. 2023 Aug;108(2):203-204.NO ABSTRACTPMID:37590869 (Source: American Family Physician)
Source: American Family Physician - August 17, 2023 Category: Primary Care Authors: Linda Speer Source Type: research
Letrozole More Effective Than Clomiphene for Infertility Treatment Among Individuals With Polycystic Ovary Syndrome
Am Fam Physician. 2023 Aug;108(2):203-204.NO ABSTRACTPMID:37590869 (Source: American Family Physician)
Source: American Family Physician - August 17, 2023 Category: Primary Care Authors: Linda Speer Source Type: research
Letrozole More Effective Than Clomiphene for Infertility Treatment Among Individuals With Polycystic Ovary Syndrome
Am Fam Physician. 2023 Aug;108(2):203-204.NO ABSTRACTPMID:37590869 (Source: American Family Physician)
Source: American Family Physician - August 17, 2023 Category: Primary Care Authors: Linda Speer Source Type: research
Letrozole More Effective Than Clomiphene for Infertility Treatment Among Individuals With Polycystic Ovary Syndrome
Am Fam Physician. 2023 Aug;108(2):203-204.NO ABSTRACTPMID:37590869 (Source: American Family Physician)
Source: American Family Physician - August 17, 2023 Category: Primary Care Authors: Linda Speer Source Type: research
